Illinois Featured Content

  • First human clinical trials of anti-cancer agent PAC-1 show promise

    Dec 22, 2022 9:45 am by Diana YatesResearch
    researchers Tim Fan and Paul Hergenrother, who developed PAC-1

    Images

    • researchers Tim Fan and Paul Hergenrother, who developed PAC-1

    Phase I clinical trial of an anti-cancer agent developed by U of I researchers found only minor side effects in patients with end-stage cancers. It stalled the growth of tumors in five people and reduced tumor size in two of those patients.